CN1144123A - Xinmaitai prescription and producing process thereof - Google Patents

Xinmaitai prescription and producing process thereof Download PDF

Info

Publication number
CN1144123A
CN1144123A CN 96108709 CN96108709A CN1144123A CN 1144123 A CN1144123 A CN 1144123A CN 96108709 CN96108709 CN 96108709 CN 96108709 A CN96108709 A CN 96108709A CN 1144123 A CN1144123 A CN 1144123A
Authority
CN
China
Prior art keywords
radix
xinmaitai
prescription
production technology
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 96108709
Other languages
Chinese (zh)
Inventor
周德铭
秦忠惠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XIANGHUI MEDICINE HI-TECH INST CHONGQING CITY
Original Assignee
XIANGHUI MEDICINE HI-TECH INST CHONGQING CITY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XIANGHUI MEDICINE HI-TECH INST CHONGQING CITY filed Critical XIANGHUI MEDICINE HI-TECH INST CHONGQING CITY
Priority to CN 96108709 priority Critical patent/CN1144123A/en
Publication of CN1144123A publication Critical patent/CN1144123A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a prescription of Chinese drug Xinmaitai and its production process. Said prescription is composed of seven Chinese medicinal materials of red sage root, chuanxiong rhizome, corydalis tuber, dutchmanspipe root, pueraria root, trichosanthes fruit and prepared licorice. By using different preparation processes of alcohol extraction, water extraction, adding auxiliary materials, granulation and tablet-forming, etc. said invention can be made into powder preparation, tablet and oral liquor with the good therapeutic action for curing coronary heart disease, cerebral arteriosclerosis and deficiency of blood supply of basilar artery, etc..

Description

The prescription of description Xinmaitai and production technology thereof
The prescription of Xinmaitai:
Radix Salviae Miltiorrhizae 10 gram Rhizoma Chuanxiongs 6 gram Rhizoma Corydalis 4 gram Radix Aristolochiaes 4 grams
Radix Puerariae 6 gram Fructus Trichosanthis 6 gram Radix Glycyrrhizae Preparatas 3 grams
Radix Salviae Miltiorrhizae blood circulation and channel invigorating in the side, stasis-dispelling and pain-killing is longer than treatment coronary heart disease, and angina pectoris is with being monarch drug.
The Rhizoma Chuanxiong promoting the circulation of QI to relieve pain can strengthen the Radix Salviae Miltiorrhizae blood circulation and channel invigorating, and the effect of stasis-dispelling and pain-killing is with being ministerial drug.
Rhizoma Corydalis is invigorated blood circulation, and regulates the flow of vital energy pain relieving; The Radix Aristolochiae regulating QI to relieve pain; The Radix Puerariae expelling pathogenic factors from muscles removes strong, the blood vessels of releiving; The Fructus Trichosanthis clearing away heat and eliminating phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, the kind obstruction of qi in the chest and cardialgia that removes, this four Chinese medicine is with being adjuvant drug.
The Radix Glycyrrhizae Preparata Yiqi and vein recovery, coordinating the actions of various ingredients in a prescription is as messenger drug.
Full side seven flavor Chinese medicines, based on monarch drug, ministerial drug is auxilliary, under the collaborative effect of assistant, messenger drug, brings into play blood circulation and channel invigorating jointly, the function of promoting the circulation of QI to relieve pain is applicable to that feel oppressed in the ambition due to the coronary heart disease, angina pectoris; Dizzy, headache due to cerebral arteriosclerosis or the basilar artery insufficiency.
Usage and consumption: oral, three times on the one, a day dosing is equivalent to crude drug in whole 39 grams.
Storage: place shady and cool dry place to preserve.
The present invention relates to the technical field of Chinese medicine three kind new medicines.
Xinmaitai is a kind of brand-new Chinese patent medicine, and its purpose is to provide a kind of new medication to select to the heart, cerebrovascular disease patient, helps this class treatment of diseases more.
One, the production technology of Xinmaitai electuary is:
1, Rhizoma Corydalis is ground into coarse powder, extracts fluid extract with alcohol percolation method.
2, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Aristolochiae, Radix Puerariae, Radix Glycyrrhizae Preparata extract three times with decocting, merge decoction liquor.
3, Rhizoma Corydalis fluid extract and three water are proposed the decoction liquor merging, mix the clear paste that is condensed into certain relative density.
4, add an amount of cyclamate and cane sugar powder in the clear paste, after the mixing, make granule with one-step-granulating method.
5, single amount packing, dress box, vanning, check, warehouse-in.
Main production equipments is:
Ethanol percolate extraction device, ethanol reclaim under reduced pressure device, multipotency extraction pot, receiver, vaporizer, one-step-granulating method, automatic packaging machine.
Xinmaitai electuary process chart is asked for an interview Figure of description 1.
Two, the production technology of Xinmaitai tablet is:
1, Rhizoma Corydalis alcohol extraction, dried cream is produced in oven dry.
2, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Aristolochiae, Radix Puerariae, Fructus Trichosanthis, Radix Glycyrrhizae Preparata water are carried, and first dense, smart dense, dried cream is produced in oven dry.
3, two kinds are broken into fine powder in the cream mixed powder.
4, add appropriate amount of auxiliary materials, granulate.
5, add an amount of disintegrating agent and magnesium stearate in made medicine grain, with tablet machine tabletting (plain sheet), packing.
6, as making coated tablet, plain sheet is sugar coating again, packing.
Main production equipments is:
Ethanol percolate extraction device, ethanol reclaim under reduced pressure device, multipotency extraction pot, receiver, vaporizer, concentrating under reduced pressure jar, blender, granulator, dehydrator, tablet machine, coating machine, packer.
Xinmaitai tablet process chart is asked for an interview Figure of description 2.
Three, the production technology of Xinmaitai oral liquid is:
1, dried cream is produced in Rhizoma Corydalis alcohol extraction, is ground into fine powder.
2, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Aristolochiae, Radix Puerariae, Fructus Trichosanthis, Radix Glycyrrhizae Preparata water are carried three times, and three decoction liquor are mixed.
3, Rhizoma Corydalis extractum is added entry and carry in the medicinal liquid, stir evenly, be concentrated to then till the clear paste of certain relative density.
4, add an amount of syrup and antiseptic, fully stir evenly.
5, with the fill of oral liquid automatic filling machine list amount.
6, dress box, vanning, check, warehouse-in.
Main production equipments is:
Ethanol percolate extraction device, ethanol reclaim under reduced pressure device, dehydrator, pulverizer, multipotency extraction pot, storage tank, vaporizer, automatic filling machine.
Xinmaitai oral liquid process chart is asked for an interview Figure of description 3.
By new patent searching, the method that adopts computer to combine with manual information retrieval has been consulted " Chinese patent database ", " Gazette of Patent for Invention ", filters out 10 pieces of pertinent literatures:
1. treat the prescription and the production method " Gazette of Patent for Invention " of angina pectoris coronary heart disease
10-7 P29
2. Chinese patent medicine " Gazette of Patent for Invention " 9-who treats angina pectoris
42 P21
3. prevent and treat the Chinese medicine Guanxintong and method for making " the patent of invention public affairs thereof of angina pectoris
Newspaper " 11-17 P19
4. Chinese medicine composition " Gazette of Patent for Invention " for the treatment of angina pectoris
12-5 P23
5. the treatment coronary heart disease heart twists method for making " the patent of invention public affairs of myocardial infarction Chinese medicine preparation
Newspaper " 12-1 P32
6. the new drug of treatment angina pectoris Chinese medicine " (Gazette of Patent for Invention " 10-
9 P37
7. novel therapeutic coronary heart disease electuary and preparation method thereof " Gazette of Patent for Invention "
9-36 P16
8. production method " Gazette of Patent for Invention " for the treatment of the coronary heart disease Chinese medicinal tablet
9-28 P17
9. treat arrhythmia type coronary heart disease " prescription and the production method of multiple arteries and veins miraculous cure "
11-4 P22
10. treat the herb liquid and the production method " (patent of invention thereof of cardiac and cerebral vascular diseases
Communique " 11-15 P22
The result is as follows:
In searching document, treatment coronary heart disease, anginal Chinese medicine preparation is more, as: " prescription of treatment angina pectoris coronary heart disease medicine has production method " (document 1), " a kind of treatment coronary heart disease; anginal Chinese patent medicine " (document 2), " preventing and treating coronary heart disease; anginal Chinese medicine Guanxintong and method for making thereof " (document 3) etc., " prescription of Xinmaitai is formed and the identical report of production technology with this patent but do not see in range of search.

Claims (4)

1, a kind of prescription of Xinmaitai and and production technology, its prescription is characterised in that it is made up of Radix Salviae Miltiorrhizae 10 gram, Rhizoma Chuanxiong 6 grams, Rhizoma Corydalis 4 grams, Radix Aristolochiae 4 grams, Radix Puerariae 6 grams, Fructus Trichosanthis 6 grams, Radix Glycyrrhizae Preparata 3 grams seven flavor Chinese medicines.
2, a kind of prescription of Xinmaitai and production technology, the production technology feature of its Xinmaitai electuary is:
Rhizoma Corydalis is ground into coarse powder, extracts with alcohol percolation method, makes fluid extract.
Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Aristolochiae, Radix Puerariae, Fructus Trichosanthis, Radix Glycyrrhizae Preparata water decoct three times, merge three times decoction liquor.
Mix with three decocting liquid with fluid extract that ethanol is carried, be condensed into the clear paste of certain relative density, add an amount of cyclamate and cane sugar powder, the reuse one-step-granulating method is granulated, the shaping of sieving, packing, check, warehouse-in.
3, a kind of prescription of Xinmaitai and production technology thereof, the production technology feature of its Xinmaitai tablet is:
The Rhizoma Corydalis alcohol extraction, dried cream is produced in oven dry.
Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Aristolochiae, Radix Puerariae, Fructus Trichosanthis, Radix Glycyrrhizae Preparata water are carried, and is first dense, smart dense, and dried cream is produced in oven dry.
Two kinds of dried cream mixed powders are broken into fine powder, add appropriate amount of auxiliary materials, granulate.In add an amount of disintegrating agent and magnesium stearate again in granulating, press plain sheet with tablet machine.As make coated tablet, place the coating machine to wrap sugar-coat plain sheet.
Packing, check, warehouse-in.
4, a kind of prescription of Xinmaitai and production technology thereof, the production technology feature of its Xinmaitai oral liquid is:
Dried cream is produced in the Rhizoma Corydalis alcohol extraction, is ground into fine powder.
Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Aristolochiae, Radix Puerariae, Fructus Trichosanthis, Radix Glycyrrhizae Preparata water are carried three times, and three decoction liquor are mixed.
The Rhizoma Corydalis dried cream powder is added entry carry in the medicinal liquid, stir evenly, be condensed into the clear paste of certain relative density then, add an amount of syrup and antiseptic, fully stir evenly, carry out the fill of list amount with automatic filling machine then.Packing, check, warehouse-in.
CN 96108709 1996-06-17 1996-06-17 Xinmaitai prescription and producing process thereof Pending CN1144123A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 96108709 CN1144123A (en) 1996-06-17 1996-06-17 Xinmaitai prescription and producing process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 96108709 CN1144123A (en) 1996-06-17 1996-06-17 Xinmaitai prescription and producing process thereof

Publications (1)

Publication Number Publication Date
CN1144123A true CN1144123A (en) 1997-03-05

Family

ID=5120064

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 96108709 Pending CN1144123A (en) 1996-06-17 1996-06-17 Xinmaitai prescription and producing process thereof

Country Status (1)

Country Link
CN (1) CN1144123A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1075360C (en) * 1999-03-01 2001-11-28 施友彬 Shixinkang capsule as one kind of nutritious food
EP1242103A4 (en) * 1999-08-27 2003-05-07 Cheil Jedang Corp Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof
CN100389793C (en) * 2005-12-12 2008-05-28 广东大光药业有限公司 Medicinal composition of radix sal viae miltiorrhizae and radix puerariae for treating cardio-cerebro uascular disease and its preparing method
CN101199680B (en) * 2007-12-12 2011-06-08 李亚萍 Oral administration Chinese medicine for treating folliculitis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1075360C (en) * 1999-03-01 2001-11-28 施友彬 Shixinkang capsule as one kind of nutritious food
EP1242103A4 (en) * 1999-08-27 2003-05-07 Cheil Jedang Corp Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof
CN100389793C (en) * 2005-12-12 2008-05-28 广东大光药业有限公司 Medicinal composition of radix sal viae miltiorrhizae and radix puerariae for treating cardio-cerebro uascular disease and its preparing method
CN101199680B (en) * 2007-12-12 2011-06-08 李亚萍 Oral administration Chinese medicine for treating folliculitis

Similar Documents

Publication Publication Date Title
CN1224614A (en) Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation
CN101513437A (en) Antifatigue Chinese pharmaceutical composition and preparation method thereof
CN1051237C (en) Meicinal prepn. "Kexianling" for curing epilepsy
CN101053621A (en) Traditional Chinese medicinal composition for treating obesity and its preparation method
CN1055638C (en) Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method
CN1205974C (en) Thirty-six ingredients capsule for treating diabetes
CN1853702A (en) Chinese medicinal preparation for lowering blood sugar, blood fat and blood pressure, improving blood flow and immune and its making method
CN1144123A (en) Xinmaitai prescription and producing process thereof
CN1546158A (en) Specific medicine for treating cancer and preparing process
CN1857697A (en) Compound Chinese medicine Anxuekang and its preparing method
CN1943756A (en) A Chinese traditional medicinal composite used for treatment of hypertension and its preparation method
CN1283285C (en) Acne treating ointment
CN1857599A (en) Medicine for lowering blood sugar, blood fat and blood pressure, raising blood flow rate and raising immunity and its preparing method
CN1050292C (en) Anticancer drug and preparing method thereof
CN1112193C (en) Chinese medicine for treating hepatitis B and hepatic fibrosis and its preparing process
CN1176794A (en) Medicine for treating masculine sterility
CN1483422A (en) Medicine for treating diabetes
CN1242767C (en) Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method
CN1843460A (en) Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method
CN101549057A (en) Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
CN1053111C (en) Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing
CN1274320C (en) Notoginseng ginkgo health care food and its preparation method
CN1103799A (en) Tonic medicine for anti senility and for prolonging person's life and the prepn. method
CN1191735A (en) Chinese medicine Yangshengbao and its production process
CN1356117A (en) Capsule 'Tangniaoshenkang' for treating diabetes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1017110

Country of ref document: HK